Of note, we also observed that the soluble form of CD163, sCD163 [36], was enriched in the CSF of pwMS and correlated with the number of PRLs, suggesting that sCD163 might represent a potential biomarker reflecting PRL status and clinical disability in MS. The gene discussed is CD163; the disease is myeloid sarcoma.